Large-scale study involving 1404 patients with stage II and III CRC demonstrated the association of BRAF mutations with the female gender, localization of tumor in the right side, older age (60 years or more), a high grade of anaplasia, and microsatellite instability. The gene discussed is BRAF; the disease is neoplasm.